Amazon Pharmacy vs DudeMeds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amazon Pharmacy
Best for fastest brand-name Foundayo delivery with the cheapest insured priceStarting at $25/mo
DudeMeds
Best for men seeking no-fee GLP-1 access with oral and injectable optionsStarting at $149/mo
Side-by-Side Comparison
| Feature | Amazon Pharmacy | DudeMeds |
|---|---|---|
| Overall Score | ✓8.7/10 | 7.2/10 |
| Starting Price | ✓$25/mo | $149/mo |
| Editorial Rating | ✓4.4 ★ /5 | 3.6 ★ /5 |
| Features | ✓6 features | 4 features |
| States Available | ✓50 | 0 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amazon Pharmacy
Pros
- ✓$1/day ($25/month) with insurance and the automatically-applied Lilly manufacturer-sponsored coupon — the cheapest brand-name Foundayo channel we've seen
- ✓Same-day delivery in nearly 3,000 US cities and towns at launch, expanding to 4,500 by year-end 2026 — most aggressive delivery footprint of any GLP-1 distribution channel
- ✓In-office, licensed-pharmacist-supported kiosks at select One Medical locations let patients walk out of an appointment with their Foundayo in hand — bypasses pharmacy lines entirely
- ✓Cash-pay $5/day ($149/month) is competitive with Ro and GoodRx for the same FDA-approved brand-name product
- ✓Real-time medication availability + transparent pricing + automatic manufacturer coupon application before checkout
- ✓Has been delivering GLP-1 medications since 2021 — operational track record on cold-chain biologic logistics
- ✓24/7 access to licensed pharmacists for clinical questions
Cons
- ✗Requires a valid existing prescription — Amazon Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (your PCP, a specialty endocrinologist, or another telehealth provider) to get the Foundayo script first
- ✗Headline $25/month price requires both insurance coverage AND the Lilly Savings Card — uninsured patients pay the $149/month cash price
- ✗Same-day delivery is geographically gated — outside the ~3,000 cities, delivery falls back to next-day, two-day, or three-day depending on remoteness
- ✗Pricing is set by Lilly's manufacturer-sponsored coupon program and could change
- ✗Does not offer compounded semaglutide or tirzepatide — brand-name only
- ✗Foundayo only at launch — Amazon Pharmacy carries other GLP-1s separately but the April 2026 announcement is Foundayo-specific
DudeMeds
Pros
- ✓Both semaglutide and tirzepatide available in oral and injectable formats
- ✓No membership fee, no doctor fee, free shipping — transparent all-in pricing from $149/mo
- ✓HSA and FSA eligible
- ✓Accepts clinic-switch patients from existing GLP-1 and TRT providers
- ✓Async consultations in most states — no video visit required
- ✓24/7 patient portal for ongoing care and medication adjustments
- ✓Fast delivery — medication typically ships within 48 hours
Cons
- ✗Men's-only branding — may not appeal to women seeking GLP-1 access
- ✗State availability not publicly disclosed — described as available in 'most states'
- ✗No visible LegitScript certification or PCAB accreditation
- ✗Newer brand with limited independent reviews
- ✗Exact dose-tier pricing beyond the $149 starting price is not disclosed on the website
Our Verdict
Amazon Pharmacy edges out DudeMeds with a higher overall score of 8.7/10 and is particularly strong for fastest brand-name Foundayo delivery with the cheapest insured price. DudeMeds remains a solid alternative, especially if you're looking for men seeking no-fee GLP-1 access with oral and injectable options.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.